WEST PHARMACEUTICAL SERVICES INC
For the period ended May 4, 2026. Filed Mar 12, 2026.
View on SEC.govAbout this filing
What shareholders are asked to vote on at a company's meeting. It is where to find what directors and top executives are paid, and who owns the most shares.
May 4, 2026 · Filed Mar 12, 2026
Contents
CEO Evaluation Process
In assessing the performance of our CEO, the independent directors engage in a robust assessment process that is managed throughout the year by our Lead Independent Director and culminates in a formal annual performance review. The assessment includes the following:
| ● | Independent directors review the CEO’s annual business objectives consisting of both qualitative and quantitative progress against the pillars of our enterprise strategy including: Customer Experience, Operational Effectiveness, Products and Services Expansion, Enterprise Capabilities, People and Culture and Financial Goals; |
| ● | The Compensation Committee’s independent consultant conducts a comprehensive analysis of West’s financial targets compared against the performance of the peer companies in our Business Segment Group; |
| ● | Quarterly, the independent directors review progress made against each objective; |
| ● | An annual evaluation of the CEO’s individual performance is conducted by the independent directors covering numerous factors such as leadership, succession planning, strategic planning, financial performance, team member development and engagement, external and internal relations and interactions with the Board; and |
| ● | An analysis of West’s operating performance and relative total shareholder return (“TSR”) over a multi-year period, a competitive benchmark analysis and other relevant information is submitted to the independent directors. |
The Committee, with input from its independent compensation consultant, carefully reviews all relevant information when developing its compensation recommendations for discussion with and approval by the independent directors of the Board.
46** ** I Compensation Tables
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.